The main components of the adaptive immune responses, the CD8+ and CD4+ T cell populations, are both armed with T cell receptors (TCRs), which can recognize respectively major histocompatibility complex (MHC) classI/ or MHC classII/tumor-derived antigen complexes (“stimulating complex”) in a highly specific and selective manner. Here, CD8A is linked to neoplasm.